SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)

NCT03552549 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
126
Enrollment
INDUSTRY
Sponsor class

Stopped This study was closed to enrollment prematurely due to sub-optimal accrual.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC